AIM To compare the effects of patient triggered ventilation (PTV) with conventional ventilation (IMV) in preterm infants ventilated for respiratory distress syndrome (RDS).
METHODS Nine hundred and twenty four babies from 22 neonatal intensive care units were assessed. They were under 32 weeks of gestation and had been ventilated for respiratory distress syndrome (RDS) for less than 6 hours within 72 hours of birth. The infants were randomly allocated to receive either PTV or IMV. Analysis was on an “intention to treat” basis. Death before discharge home or oxygen therapy at 36 weeks of gestation; pneumothorax while ventilated; cerebral ultrasound abnormality nearest to 6 weeks; and duration of ventilation in survivors were the main outcome measures.
RESULTS There was no significant difference in outcome between the two groups. Unadjusted rates for death or oxygen dependency at 36 weeks of gestation were 47.4% and 48.7%, for PTV and IMV, respectively; for pneumothorax these were 13.4% and 10.3%; and for cerebral ultrasound abnormality nearest to 6 weeks these were 35.4% and 36.9%. Median duration of ventilation for survivors in both groups was 6 days. Overall, 79% of babies received only their assigned ventilation. PTV babies were more likely to depart from their intended ventilation (27%vs 15%). The trend towards higher pneumothorax rates with PTV occurred only in infants below 28 weeks of gestation (18.8% vs 11.8%).
CONCLUSIONS There was no observed benefit from the use of PTV, with a trend towards a higher rate of pneumothorax under 28 weeks of gestation. Although PTV has a similar outcome to IMV for treatment of RDS in infants of 28 weeks or more gestation, within 72 hours of birth, it was abandoned more often. It cannot be recommended for infants of less than 28 weeks' gestation with the ventilators used in this study.
- patient triggered ventilation
- respiratory distress syndrome
- intermittent positive pressure ventilation
Statistics from Altmetric.com
- patient triggered ventilation
- respiratory distress syndrome
- intermittent positive pressure ventilation
Greenough et al 1observed that active expiration against ventilator inflation was associated with a high risk of pneumothorax and that this could be prevented by selective paralysis. It is not always possible clinically to identify infants actively expiring against the ventilator,2 and paralysis has several adverse effects, including the prolongation of ventilation and fluid retention. This led to attempts to achieve synchronous ventilation, with matching of phase and rate of the infant's and the ventilator's respiratory cycles. These have included ventilating infants at fast rates,3setting the ventilator to the infant's inspiratory and expiratory times,4 and patient triggered ventilation (PTV).
PTV aims to provide phase and rate matched ventilation such that ventilator inflation only occurs during the infant's inspiratory phase and does not extend into its period of expiration. Short term benefits from PTV have been shown in randomised controlled trials involving small numbers of infants. These include improvement in oxygenation,5-7 improved CO2elimination,6 increased minute volume,7shorter time to extubation,8-10 decreased work of breathing,11 12 decreased cerebral blood flow velocity variability13 and decreased beat to beat blood pressure fluctuations.12 It is also claimed that PTV is less stressful for babies and produces a smoother course of ventilation. A reduction in plasma adrenaline concentrations in babies changed from intermittent mandatory ventilation (IMV) to PTV has been shown in one study.14
Two major alternative modes have been tried—namely, PTV where every patient inspiration triggers a ventilator breath—and synchronised intermittent mandatory ventilation (SIMV), where each breath triggers the ventilator only if it falls within a time window set by the operator. One prospective, randomised controlled trial compared SIMV with slow rate mandatory ventilation and included the outcomes of pneumothorax and chronic lung disease of prematurity.15Despite the finding of a significantly lower rate of oxygen dependence at 36 weeks of gestation in infants under 1 kg birthweight on SIMV, there was no significant effect on mortality or pneumothorax rates.
Clinical experience of using the SLE 2000, a jet ventilator capable of trigger ventilation using an airway pressure sensor, led to policies for setting up, adjusting, and weaning babies from PTV. This ventilator had already proved capable of ventilating premature infants with respiratory distress syndrome from birth to extubation.16This prompted a multicentre open randomised controlled trial to investigate the effects of PTV compared with IMV in preterm infants ventilated for respiratory distress syndrome (RDS). Currently available neonatal trigger ventilators using an airway sensor were used.
The study was designed to compare PTV and IMV in RDS in respect of four main outcomes: hospital mortality or the need for oxygen treatment at 36 weeks of gestation; pneumothorax; cerebral ultrasound abnormality nearest to 36 weeks of gestation; and the duration of ventilation in survivors.
Sample size predictions were based on the rates of pneumothorax observed in all controlled trials, reporting rates in infants treated with surfactant.17-26 Rates varied from 5 to 36%, with a mean of 14.5%. A sample size of 1760 gave an 80% power of detecting a difference between rates of 17% and 12%, regarded as significant at the 5% level in a two tailed test of proportions. These differences were the smallest that could reasonably be considered of clinical importance. The rate of the other primary outcome—survival to discharge home, having been oxygen independent from 36 weeks of gestation—was estimated at 80%. The sample size should detect a difference between rates of 82% and 75%, with a power of 95%, using a two tailed test and significance at the 5% level. In March 1996, after the trial had continued for three years, it became clear that the sample size was not achievable within the funded time. It was agreed that the closing date for recruitment should be set to achieve a sample size of around 1000 babies. The sample size actually achieved when recruitment closed after 4 years 7 months gave an 80% power to detect pneumothorax rate differences of 18.5% and 12%, and oxygen free survival rates of 82% and 74%.
The study included 22 neonatal intensive care units who had at least one suitable trigger ventilator (SLE 2000 or Dräger babylog 8000) and who were willing to randomly allocate babies to PTV or IMV. Written agreed guidelines on the ventilation techniques were available in participating units. Collaborators were instructed to start babies on PTV with inspiratory times of between 0.2 and 0.25 seconds, the ventilator set to trigger at each inspiratory effort and a backup rate of 35 breaths a minute. Those receiving IMV had ventilator rates set initially at between 40 and 65 breaths a minute, with instructions to increase the rate as required, and initial inspiratory times between 0.2 and 0.6 seconds. In both modes of ventilation inspiratory and expiratory pressures and oxygen concentrations were chosen by the attending clinicians. In PTV mode collaborators were instructed to wean by progressively reducing peak inspiratory pressure to a minimum of 8 to 10 cm H2O. In IMV mode, weaning was accomplished by reducing peak inspiratory pressure to a minimum of 16 cm H2O and then by reducing the rate.
Babies were eligible to be entered if they were less than 32 completed weeks of gestation, required ventilation within 72 hours of birth, and had been ventilated for no more than 6 hours at randomisation. A ventilator capable of delivering PTV was required, and the clinical and radiological features had to be compatible with RDS. Babies were excluded if there was clinical or radiological evidence of a major congenital malformation or inhalational pneumonitis at trial entry.
The mode of ventilation was randomly allocated by telephone, according to a written protocol, after oral or written parental consent had been obtained. Participating centres were asked to record the birthweight, gestation, and clinical severity CRIB (clinical risk index for babies) score,27 together with the reason(s) for non-randomisation of all otherwise eligible infants who were not entered into the trial. Within each centre, randomisation was performed in blocks to ensure a similar distribution of babies in each arm of the study as it proceeded.
Infants were required to receive the form of ventilation to which they were assigned from birth to final extubation. Trial entry was stratified by centre. Clinicians were allowed the discretion to change the baby from the assigned mode of ventilation on clinical grounds, although they were discouraged from doing so. The main reason for, and date of altering, the mode of ventilation was recorded.
Local research ethics committee approval was obtained in all participating centres.
Clinical information was collected on antenatal steroid use, mode of delivery, postnatal surfactant administration, whether there was a multiple birth, the sex, birthweight, and gestation of the baby, CRIB score, and details of ventilation, outcomes, departure from assigned mode of ventilation and complications and cause of death. A trial report form was completed at the time of discharge from hospital or transfer to another unit. Two different individuals created separate computer databases from these report forms, and each was checked for completeness and accuracy.
A cranial ultrasound scan was required at 6 weeks of postnatal age, or as near to that date as possible before discharge home in all infants. Ventricular size was assessed using the ventricular index of Leveneet al.28 The scan was interpreted by the most experienced doctor in each unit. The scan was reported by a doctor who was usually unaware of the treatment assignment. The scan was scored separately for each hemisphere as follows. Haemorrhage (0 no haemorrhage, 1 localised subependymal or choroidal haemorrhage, 2 intraventricular haemorrhage, 3 parenchymal haemorrhagic lesion); ventricular size (0 no dilatation, 1 dilatation less than 4 mm above the 97th centile, 2 hydrocephalus greater than 4 mm above 97th centile); parenchymal cysts (0 no cysts, 1 porencephalic cyst, 2 cystic leucomalacia).
Details of the method of diagnosis of pneumothorax made by the clinicians were extracted by the trial coordinator from the case notes. Relevant chest x-rays were reviewed by one clinician (JHB) blind to the treatment allocation. The decision to continue oxygen treatment was determined according to each unit's existing policy. The minimum oxygen saturation in air during a period of sleep at 36 weeks of gestation was required for all babies not in oxygen, to confirm that they were truly oxygen independent. Thirty five babies had minimum oxygen saturations of less than 90% at 36 weeks of gestation; adding these babies to the oxygen dependent group made no difference to the conclusions of the study, and they were therefore analysed as though oxygen independent.
The two main ventilators used in the study differed in design. The SLE 2000 is a valveless jet ventilator triggered by changes in airway pressure, the Dräger babylog 8000 is a solenoid ventilator triggered by changes in air flow. Provision was made to assign the type of ventilator randomly as well as the mode of ventilation. This was only attempted at three centres that had both types of ventilator. As most centres used one type of ventilator, and large centre effects on the outcomes were seen, a logistic regression model was used to look for a possible association with type of ventilator, taking into account other significant factors—namely, CRIB score and centre.
Analysis was by an intention to treat basis. It was agreed that only differences in the key outcome of survival to discharge without oxygen dependence at 36 weeks, significant at the 0.15% level (p<0.0015) using a two tailed test, would stop recruitment to the trial, to avoid misleading deductions being drawn from early results.29 A confidential interim analysis of the study was carried out once the first 400 babies had been recruited, and presented to the independent data monitoring committee which recommended continuing the trial.
Overall, 924 babies were recruited to the trial. One additional infant was randomly assigned, but immediately recognised as not being eligible: no information was collected and the infant was not included in analysis. Two babies assigned to IMV were subsequently realised to be 32 and 33 weeks of gestation; they were analysed as though eligible. Three infants died with congenital abnormalities not evident at randomisation. One each had aortic stenosis, congenital cardiomyopathy, and hypoplastic left heart syndrome. They were all analysed according to their assigned mode of ventilation. Randomisation details are shown in fig 1.
Information was available on 1378 eligible babies born at participating centres during the period of collaboration. The most common stated reasons for non-randomisation were: no consent sought for any reason (149 babies), accidental oversight (88 babies), no ventilator available for randomisation (52 babies), and parental refusal (52 babies). There was no significant difference in birthweight or gestation between babies who were not randomised and those who were. However, non-randomised babies had a significantly higher illness severity score (mean (SD) CRIB score 8.1 (5.6) vs 6.1 (4.2); t=6.26, p<0.001).
The babies assigned to the two modes of ventilation were very comparable at trial entry (table 1).
Overall, 192 infants (21%) departed from their assigned mode of ventilation at some point (fig 1). There was a significantly higher rate of departure from the assigned mode of ventilation in babies receiving PTV (124/463 (27%) vs 68/458 (15%), χ2 19.2, p<0.0001). Forty five babies randomised to PTV had their mode of ventilation changed because of failure to trigger the ventilator. Babies receiving PTV who departed from their assigned mode of ventilation were significantly more likely to do so within the first 72 hours than those on IMV (60/114 (53%)vs 16/62 (26%), χ2 10.7, p<0.005).
The major outcomes of the study are shown in table 2. There was no significant difference for any of the outcomes between the two treatment groups. Odds ratios (95% confidence limits) for death or chronic lung disease, pneumothorax, and ultrasound abnormality were 0.95 (0.73 to 1.23), 1.35 (0.90 to 2.02), 0.94 (0.71 to 1.24).
The time to extubation in survivors was not significantly different using the logrank test, with death as a censored event (p=0.67).
In a posthoc analysis, pneumothoraces were more commonly seen in infants below 28 weeks receiving PTV rather than IMV (40/213, 18.8%vs 22/186, 11.8%, respectively; odds ratio 1.72, 95% confidence intervals 0.98 to 3.02). Among infants of 28 weeks and above, pneumothoraces occurred in 22/250, 8.7% of those receiving PTV and in 25/272, 9.2% of those receiving IMV (odds ratio 0.95, 95% confidence intervals 0.52 to 1.74). This difference in effect by gestation was not seen for the other outcomes.
The rates of intracerebral parenchymal haemorrhage in the PTV and IMV groups were 9.4% and 7.1%, and of cystic leucomalacia 2.4% and 2.9%, respectively.
One hundred and six deaths occurred in the PTV group (23%) and 86 in the IMV group (19%). Most deaths (92 of 192) occurred in the first week. Post mortem examinations were undertaken in 50 (26%). The main cause of death was respiratory failure in 111 infants. The second commonest cause of death was intraventricular haemorrhage in 16 babies.
The most frequent complications recorded were septicaemia in 181 (15 died), patent ductus arteriosus in 163 (no directly attributable deaths), and necrotising enterocolitis in 85 infants (10 died). There was no significant difference in the rate of any complication between the two groups. Forty two babies had positive blood cultures in the first 72 hours, the most common organisms isolated beingStaphylococcus epidermidis, group B streptococcus, Escherichia coli, Haemophilus influenzae and Staphylococcus aureus.
One hundred and twenty babies in three centres were randomly assigned to their type of ventilator, and no significant differences in outcome by type of ventilator were seen. In a logistic regression model, there was a non-significant trend towards a higher rate of pneumothorax (odds ratio 1.74, 95% confidence intervals 0.89 to 3.39) and death or chronic lung disease (odds ratio 1.34, 95% confidence intervals 0.84 to 2.15), and a non-significant trend towards a lower rate of abnormal ultrasound scan around 6 weeks (odds ratio 0.69, 95% confidence intervals 0.41 to 1.15), in infants ventilated with the Dräger babylog 8000.
There was no observed benefit from the use of PTV, as practised in this trial. The 95% confidence limits are such that any effect not seen because of type 2 errors would be small. There was a non-significant trend towards a higher rate of pneumothorax in the trigger ventilated babies, which appeared to be confined to infants under 28 weeks of gestation, with an upper 95% confidence limit for the odds ratio of 2.
Using the ventilators in this study, PTV may not produce any greater synchrony than IMV; synchrony might have occurred more frequently in PTV mode but without benefit; and synchronous ventilation may only be achievable in infants with mild RDS or in more mature infants. The SLE 2000 ventilator used in most infants is said30 to be prone to auto-triggering (spontaneous ventilator inflations untriggered by the infant) at the highest sensitivity setting. Participating clinicians were aware of this possibility, but the phenomenon is not easy to detect clinically. A recent study31 showed a high rate of asynchrony in infants of 28 weeks or less of gestation with the two main ventilators used in trigger mode in this study. At least some of the babies with the rates of mandatory ventilation used in this study will have had ventilation that was synchronous with the ventilator through a process of entrainment.32 33
The shorter inspiratory times permitted in PTV mode might have resulted in reduced tidal volumes.34 However, in previous studies of triggered ventilation, tidal volumes have not been compromised by inspiratory times within the range used in this study.31 35 36 One study31 found a significant reduction in asynchrony rates (triggered inflation extending into expiration) with shorter inspiratory times in the VIP Bird ventilator, suggesting that short inspiratory times are beneficial in PTV mode.
The performance of different trigger ventilators and of different trigger sensors varies, and there is no agreed optimum system.37-39 However, the two neonatal ventilators used are both said to have short trigger delays averaging less than 100 milliseconds, and to be sufficiently sensitive to pick up most infant breaths, at least in more mature infants.40 41
In a study of 10 infants of 28 weeks of gestation or less Dimitriou et al 31 found that a significantly higher proportion of breaths triggered the ventilator using the Dräger babylog 8000 ventilator compared with the SLE 2000. Most infants in this study were ventilated with the SLE 2000. Although the study design allowed randomisation between airway pressure triggered and airflow triggered ventilators, very few centres had both ventilators available. The magnitude of the non-significant associations with three outcomes in a logistic regression model would require a study involving over 2000 babies to achieve sufficient power to establish whether these differences are real, but emphasises the importance of considering the effects of different ventilator performance. The associations of mode of ventilation with the main outcomes were not altered by the use of this logistic regression model, confirming that the study conclusions are robust.
The results of this study are similar to those of the one multicentre randomised controlled trial of SIMV compared with conventional ventilation15 in 327 infants. The study involved multiple analyses, raising the possibility of type I errors. Despite a significant reduction in the duration of ventilation with SIMV in infants of over 2 kg, and in oxygen dependency at 36 weeks of gestation in infants less than 1 kg, there was no overall difference in the rate of mortality, pneumothoraces, or of severe intraventricular haemorrhage. The conventional mode of ventilation used in the study involved rates of around 30 breaths per minute, which some would consider suboptimal.42 43
Infants receiving IMV in this study were started on rates of 60 breaths a minute or above in all but one centre, and maintained above this rate except during weaning. The backup rate in the PTV group was set at a level designed44 to minimise untriggered breaths while maintaining ventilation in apnoeic babies. The written guidelines permitted clinicians to increase this backup rate in persistent apnoea, thus avoiding slower rates of ventilation in such circumstances. It is therefore unlikely that differences in ventilator rate between the two modes of ventilation contributed to the outcome.
Did the clinicians in the trial apply the technique of triggered ventilation correctly? Many centres already had experience of PTV. The method had been developed from observations of preterm infants on PTV and from short term randomised controlled trials involving small numbers of infants. The trial co-ordinator visited each unit before randomisation started and briefed both medical and nursing staff in the technique. Written protocols with details of both techniques of ventilation were available at each centre throughout the study. As some units were randomising infants for 4 years any initial difficulties should have been resolved within that time. However, other treatments given to infants might have interfered with successful triggering. The initial experience of PTV in one centre16 reported a lower rate of pneumothoraces than that achieved in the trial. At that time, theophylline was used routinely in trigger ventilated babies, and morphine was used very infrequently. These practices had changed by the time the trial started. Both theophylline and morphine use are likely to influence the baby's respiratory efforts and therefore the successful achievement of synchrony in trigger mode.
PTV was abandoned more often than IMV. This difference was partly explained by the infants whose mode of ventilation was changed because of failure to trigger the ventilator. The most premature babies and those who subsequently died were more likely to have their mode of ventilation changed. It is not surprising that infants had a change in their mode of ventilation when their survival was in doubt. However, most babies who subsequently died received only their assigned mode of ventilation. There was no significant difference in any of the outcomes among infants who received only their assigned mode of ventilation.
In conclusion, there was no convincing evidence of a beneficial effect of a policy of using PTV in preterm infants with RDS on rates of death and chronic lung disease, pneumothorax or cerebral ultrasound abnormality. The duration of ventilation was identical. With these results, together with the trend towards a higher rate of pneumothorax, it might be prudent to avoid PTV in infants less than 28 weeks who ventilated for RDS using either the SLE 2000 or Dräger babylog 8000 until the results of further studies become available.
Trial collaborators (numbers are totals of babies recruited by each centre):
JH Baumer, M Hunt Derriford Hospital, Plymouth 136
M Quinn, A Busfield. Royal Devon & Exeter Hospital 135
PM Barnes, J McFarlane. Al Corniche Hospital, Abu Dhabi 106
HD Dellagrammaticas, C Christodoulou. Aglaia Kyriakou Children's Hospital, Athens, Greece 88
P Daish, T Pollard. Northampton General Hospital 72
D McMillan, L Bourcier. Foothills Hospital, Calgary, Alberta, Canada 61
J Smyth, J Hume. Royal Berkshire Hospital, Reading 61
I Verber, L Clarke. North Tees General Hospital, North Tees 49
RD Clifford, S Townsend. Dorset County Hospital, Dorchester 38
M Watkinson, M Cebula. Birmingham Heartlands Hospital 34
EE Shoo, S Appleton. Tameside General Hospital 29 MP Ward Platt, M Smith. Royal Victoria Hospital, Newcastle upon Tyne 26
JWT Benson, D Hatton. Queens Park Hospital, Blackburn 14
R Jones, C Burden. Wexham Park Hospital, Slough 14
AJ Bradbury, L Goodwin. Wythenshawe Hospital, Manchester 13
CH Cheetham, SB Ang. Wycombe General Hospital, High Wycombe 13
R Brown, Z Fazilahmed. Stoke Mandeville Hospital, Aylesbury 11
R Welch, C Smith. Royal Shrewsbury Hospital 8
MP White, J Sangster. Southern General Hospital, Glasgow 6
R Miles, C Nunns. Hinchingbrooke Hospital 5
A Shah, C Harper. North Middlesex Hospital, London 4
D Robinson, M Chan. King George Hospital, Goodmayes, Essex 1
The paper was written with assistance from the trial collaborators.
The trial was funded by a grant of 97000 from the NHS R&D Directorate.
SLE Ltd provided a desktop computer for research coordinator.
The author representing the Trigger Ventilation trial would like to acknowledge the following people:
Trial co-ordinators: Sue Ellis, Tom Mill
Trial statistician: David Wright
Data Monitoring Committee: David Field, Diana Ellis
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.